Clinical Trial Update: Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 cord blood transplantation trial for sickle cell disease and beta-thalassemia has completed, with results reported from the completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hematologic Diseases, Anemia, Sickle Cell | Phase 2 | Status: COMPLETED